Chimerix to Report Third Quarter 2022 Financial Results and Provide an Operational Update on November 3, 2022
Chimerix (NASDAQ:CMRX) will host a live conference call on November 3, 2022, at 8:30 a.m. ET to report its financial results for Q3 2022, ending September 30, 2022. The event aims to provide insights into the company’s business overview. Investors can join by dialing (646) 307-1963 for domestic calls or (800) 715-9871 for international calls, with the conference ID 2765632. A live audio webcast will also be available on Chimerix's website, and an archived version will be accessible shortly after the event.
- Upcoming conference call to report financial results indicates transparency and engagement with investors.
- None.
DURHAM, N.C., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend lives of patients facing deadly diseases, today announced that it will host a live conference call and audio webcast on Thursday, November 3, 2022 at 8:30 a.m. ET to report financial results for the third quarter ended September 30, 2022, and to provide a business overview.
To access the live conference call, please dial (646) 307-1963 (domestic) or (800) 715-9871 (international) at least five minutes prior to the start time, and refer to conference ID 2765632. A live audio webcast of the call will also be available on the Investors’ section of the Company's website, www.chimerix.com. An archived webcast will be available on the Chimerix website approximately two hours after the event.
About Chimerix
Chimerix is a biopharmaceutical company with a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The Company’s most advanced clinical-stage development program, ONC201, is in development for H3 K27M-mutant glioma.
CONTACTS:
Michelle LaSpaluto
919 972-7115
ir@chimerix.com
Will O’Connor
Stern Investor Relations
212-362-1200
will@sternir.com
FAQ
When is Chimerix's next earnings call?
What will Chimerix discuss during the Q3 earnings call?
How can I access Chimerix's conference call?